name: positive regulation of hexadecanal metabolic process

description: Any process that activates or increases the frequency, rate or extent of hexadecanal metabolic process.


name: positive regulation of CREB transcription factor activity

category: biolink:BiologicalProcess biolink:Occurrent biolink:OntologyClass biolink:BiologicalProcessOrActivity biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing biolink:PhysicalEssenceOrOccurrent

description: Any process that activates or increases the frequency, rate or extent of activity of the transcription factor CREB.


name: regulation of transcription by RNA polymerase V

description: Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase V.


name: negative regulation of interleukin-11 production

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-11 production.


name: regulation of type III interferon production

description: Any process that modulates the frequency, rate, or extent of type III interferon production. Interferon lambda is the only member of the type III interferon found so far.


name: regulation of mast cell cytokine production

description: Any process that modulates the frequency, rate, or extent of mast cell cytokine production.


name: regulation of thiamine biosynthetic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of thiamine.


regulation of rRNA stability

description: Any process that modulates the propensity of rRNA molecules to degradation. Includes processes that both stabilize and destabilize rRNAs.


name: positive regulation of phosphatidate phosphatase activity

description: Any process that activates or increases the frequency, rate or extent of phosphatidate phosphatase activity.


name: negative regulation of estrogen biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of estrogen biosynthetic process.


name: positive regulation of mRNA cis splicing, via spliceosome

description: Any process that activates or increases the frequency, rate or extent of mRNA cis splicing, via spliceosome.


name: negative regulation of interleukin-22 production

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-22 production.


name: regulation of nucleotide catabolic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of nucleotides.


name: positive regulation of miRNA transcription

description: Any process that activates or increases the frequency, rate or extent of microRNA (miRNA) gene transcription.


name: regulation of tatiopterin metabolic process

description: Any process that modulates the frequency, rate or extent of tatiopterin metabolic process.


name: negative regulation of chemokine (C-C motif) ligand 20 production

description: Any process that stops, prevents or reduces the frequency, rate or extent of chemokine (C-C motif) ligand 20 production.


name: negative regulation of autophagy of mitochondrion

description: Any process that stops, prevents or reduces the frequency, rate or extent of mitochondrion degradation by autophagy.


name: negative regulation of UDP-N-acetylglucosamine biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of the UDP-N-acetylglucosamine biosynthetic process.


regulation of RNA splicing

description: Any process that modulates the frequency, rate or extent of RNA splicing, the process of removing sections of the primary RNA transcript to remove sequences not present in the mature form of the RNA and joining the remaining sections to form the mature form of the RNA.


name: regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria

description: Any process that modulates the frequency, rate, or extent of biosynthesis of antibacterial peptides active against Gram-negative bacteria.


name: positive regulation of sphingolipid biosynthetic process

description: Any process that increases the rate, frequency or extent of sphingolipid biosynthesis. Sphingolipid biosynthesis is the chemical reactions and pathways resulting in the formation of sphingolipids, any of a class of lipids containing the long-chain amine diol sphingosine or a closely related base (a sphingoid).


name: regulation of integrin biosynthetic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of integrins.


name: regulation of chitin biosynthetic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of chitin.


regulation of interleukin-17 production

description: Any process that modulates the frequency, rate, or extent of production of any member of the interleukin-17 family of cytokines.


name: positive regulation of mRNA catabolic process

description: Any process that increases the rate, frequency, or extent of a mRNA catabolic process, the chemical reactions and pathways resulting in the breakdown of RNA, ribonucleic acid, one of the two main type of nucleic acid, consisting of a long, unbranched macromolecule formed from ribonucleotides joined in 3',5'-phosphodiester linkage.


name: nuclear-transcribed mRNA catabolic process, no-go decay

description: The chemical reactions and pathways resulting in the breakdown of the transcript body of a nuclear-transcribed mRNA with stalls in translation elongation.


name: positive regulation of interleukin-4 production

description: Any process that activates or increases the frequency, rate, or extent of interleukin-4 production.


name: regulation of cardiolipin metabolic process

description: Any process that modulates the frequency, rate or extent of cardiolipin metabolic process.


positive regulation of lipophagy

description: Any process that activates or increases the frequency, rate or extent of lipophagy.


RNA destabilization

description: Any process that decreases the stability of an RNA molecule, making it more vulnerable to degradative processes.


name: negative regulation of chemokine (C-X-C motif) ligand 9 production

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of production of chemokine (C-X-C motif) ligand 9.


regulation of mRNA catabolic process

description: Any process that modulates the rate, frequency, or extent of a mRNA catabolic process, the chemical reactions and pathways resulting in the breakdown of RNA, ribonucleic acid, one of the two main type of nucleic acid, consisting of a long, unbranched macromolecule formed from ribonucleotides joined in 3',5'-phosphodiester linkage.


name: positive regulation of interleukin-10 production

description: Any process that activates or increases the frequency, rate, or extent of interleukin-10 production.


name: positive regulation of sulfate assimilation

description: Any process that activates or increases the frequency, rate or extent of sulfate assimilation.


name: positive regulation of (R)-mevalonic acid biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of (R)-mevalonic acid biosynthetic process.


name: negative regulation of antibacterial peptide biosynthetic process

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of antibacterial peptide biosynthesis.


regulation of interleukin-35 production

description: Any process that modulates the frequency, rate, or extent of interleukin-35 production.


name: regulation of UDP-glucose catabolic process

description: Any process that modulates the rate, frequency or extent of UDP-glucose catabolism. UDP-glucose catabolic processes are the chemical reactions and pathways resulting in the breakdown of UDP-glucose, uridinediphosphoglucose, a substance composed of glucose in glycosidic linkage with uridine diphosphate.


name: positive regulation of capsule polysaccharide biosynthetic process

description: Any process that activates, maintains or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of polysaccharides that make up the capsule, a protective structure surrounding some species of bacteria and fungi.


mRNA catabolic process

description: The chemical reactions and pathways resulting in the breakdown of mRNA, messenger RNA, which is responsible for carrying the coded genetic 'message', transcribed from DNA, to sites of protein assembly at the ribosomes.


name: epigenetic programming of gene expression

description: A epigenetic process that happens during embryonic development that modulates gene expression potential at later stages of development of the organism, including the adult. Epigenetic regulation takes place via chromatin remodeling either by modifying higher order chromatin fiber structure, nucleosomal histones, or cytosine DNA methylation.


name: regulation of mitochondrial mRNA catabolic process

description: Any process that modulates the frequency, rate or extent of mitochondrial mRNA catabolic process.


regulation of pre-miRNA processing

description: Any process that modulates the frequency, rate or extent of pre-microRNA processing.


name: negative regulation of removal of superoxide radicals

description: Any process that stops, prevents or reduces the frequency, rate or extent of removal of superoxide radicals.


name: negative regulation of phosphatidylserine metabolic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidylserine metabolic process.


name: regulation of nitric-oxide synthase biosynthetic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of a nitric-oxide synthase enzyme.


name: nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay

description: The chemical reactions and pathways resulting in the breakdown of the nuclear-transcribed mRNA transcript body of an mRNA in which an amino-acid codon has changed to a nonsense codon; occurs when the 3' end is not protected by a 3'-poly(A) tail; degradation proceeds in the 3' to 5' direction.


name: induction of phytoalexin biosynthetic process

description: The activation of the chemical reactions and pathways resulting in the formation of phytoalexins, low-molecular mass, lipophilic antimicrobial compounds that accumulate rapidly at sites of incompatible pathogen infection.


name: regulation of superoxide metabolic process

description: Any process that modulates the rate, frequency, or extent of superoxide metabolism, the chemical reactions and pathways involving superoxide, the superoxide anion O2- (superoxide free radical), or any compound containing this species.


name: regulation of fumagillin biosynthetic process

description: Any process that modulates the frequency, rate or extent of fumagillin biosynthetic process.


name: positive regulation of sarcinapterin metabolic process

description: Any process that activates or increases the frequency, rate or extent of sarcinapterin metabolic process.


name: regulation of purine nucleotide biosynthetic process

description: Any process that modulates the frequency, rate or extent of purine nucleotide biosynthetic processes.


name: regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay

description: Any process that modulates the frequency, rate or extent of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay.


name: regulation of macrophage colony-stimulating factor production

description: Any process that modulates the frequency, rate or extent of macrophage colony-stimulating factor production.


regulation of interleukin-27 production

description: Any process that modulates the frequency, rate, or extent of interleukin-27 production.


name: negative regulation of heptadecane biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of heptadecane biosynthetic process.


name: positive regulation of sulfur metabolic process

description: Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving sulfur or compounds containing sulfur.


name: nuclear mRNA surveillance of mRNP export

description: The set of processes involved in identifying and degrading incorrectly formed or aberrant nuclear mRNPs docked at the nuclear pore complex prior to export to the cytoplasm.


name: positive regulation of transcription from RNA polymerase II promoter by glucose

description: Any process involving glucose that activates or increases the rate of transcription from an RNA polymerase II promoter.


name: positive regulation of ent-pimara-8(14),15-diene biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of ent-pimara-8(14),15-diene biosynthetic process.


name: positive regulation of antibacterial peptide production

description: Any process that activates or increases the frequency, rate, or extent of antibacterial peptide production.


name: negative regulation of post-transcriptional gene silencing

description: Any process that decreases the frequency, rate or extent of the inactivation of gene expression by a posttranscriptional mechanism.


name: positive regulation of transforming growth factor beta2 production

description: Any process that activates or increases the frequency, rate, or extent of production of transforming growth factor-beta2.


name: regulation of MHC class I biosynthetic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of MHC class I.


name: regulation of reactive oxygen species biosynthetic process

description: Any process that modulates the frequency, rate or extent of reactive oxygen species biosynthetic process.


name: positive regulation of camalexin biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of camalexin biosynthetic process.


name: negative regulation of superoxide anion generation

description: Any process that stops, prevents, or reduces the frequency, rate or extent of enzymatic generation of superoxide by a cell.


name: negative regulation of ent-pimara-8(14),15-diene biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of ent-pimara-8(14),15-diene biosynthetic process.


name: positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity

description: Any process that increases the rate, frequency or extent of fructose 1,6-bisphosphate 1-phosphatase activity. Fructose 1,6-bisphosphate 1-phosphatase activity is the catalysis of the reaction: D-fructose 1,6-bisphosphate + H2O = D-fructose 6-phosphate + phosphate.


name: negative regulation of sulfur metabolic process

description: Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving sulfur or compounds containing sulfur.


name: negative regulation of B cell cytokine production

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of B cell cytokine production.


name: positive regulation of polynucleotide 3'-phosphatase activity

description: Any process that activates or increases the frequency, rate or extent of polynucleotide 3'-phosphatase activity.


name: negative regulation of tridecane biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of tridecane biosynthetic process.


name: regulation of photosynthesis, light reaction

description: Any process that modulates the frequency, rate or extent of the light-dependent reaction of photosynthesis.


name: nuclear-transcribed mRNA catabolic process

description: The chemical reactions and pathways resulting in the breakdown of nuclear-transcribed mRNAs in eukaryotic cells.


regulation of sulfate assimilation

description: Any process that modulates the frequency, rate or extent of sulfate assimilation.


name: negative regulation of phospholipid metabolic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of phospholipid metabolic process.


name: negative regulation of cellular biosynthetic process

description: Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of substances, carried out by individual cells.


name: regulation of glycolytic fermentation to ethanol

description: Any process that modulates the frequency, rate or extent of glucose catabolic process to ethanol.


name: regulation of hydrogen peroxide biosynthetic process

description: Any process that modulates the rate, frequency or extent of hydrogen peroxide biosynthesis. The chemical reactions and pathways resulting in the formation of hydrogen peroxide (H2O2), a potentially harmful byproduct of aerobic cellular respiration which can cause damage to DNA.


name: regulation of nonadec-1-ene biosynthetic process

description: Any process that modulates the frequency, rate or extent of nonadec-1-ene biosynthetic process.


name: regulatory ncRNA-mediated heterochromatin formation

description: A heterochromatin formation-based gene silencing process mediated by a regulatory non-coding RNA molecule that occur before the beginning of trancription.


name: positive regulation of phosphate metabolic process

description: Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving phosphates.


name: regulation of chemokine (C-C motif) ligand 6 production

description: Any process that modulates the frequency, rate, or extent of production of chemokine (C-C motif) ligand 6 (CCL6).


name: positive regulation of guanylate cyclase activity

description: Any process that activates or increases the frequency, rate or extent of guanylate cyclase activity.


regulation of piRNA transcription

description: Any process that modulates the frequency, rate or extent of the synthesis of a piRNA.


name: negative regulation of antimicrobial peptide biosynthetic process

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of antimicrobial peptide biosynthesis.


positive regulation of reticulophagy

description: Any process that increases the frequency, rate or extent of reticulophagy.


name: negative regulation of sarcinapterin metabolic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of sarcinapterin metabolic process.


name: regulation of ascospore wall beta-glucan biosynthetic process

description: Any process that modulates the rate, frequency or extent of ascospore wall beta-glucan biosynthetic process, the chemical reactions and pathways resulting in the formation of beta-glucans, compounds composed of glucose residues linked by beta-D-glucosidic bonds, found in the walls of ascospores.


name: negative regulation of myeloid dendritic cell cytokine production

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of myeloid dendritic cell cytokine production.


name: regulation of fructose 1,6-bisphosphate 1-phosphatase activity

description: Any process that modulates the rate, frequency or extent of fructose 1,6-bisphosphate 1-phosphatase activity. Fructose 1,6-bisphosphate 1-phosphatase activity is the catalysis of the reaction: D-fructose 1,6-bisphosphate + H2O = D-fructose 6-phosphate + phosphate.


name: negative regulation of photosynthesis, light reaction

description: Any process that stops, prevents, or reduces the frequency, rate or extent of the light-dependent reaction of photosynthesis.


name: regulation of hydrogen peroxide catabolic process

description: Any process that modulates the frequency, rate or extent of hydrogen peroxide catabolic process.


name: regulation of cellular organohalogen metabolic process

description: Any process that modulates the rate, frequency or extent of the chemical reactions and pathways involving organohalogen compounds, as carried out by individual cells.


name: positive regulation of interleukin-20 production

description: Any process that activates or increases the frequency, rate, or extent of interleukin-20 production.


name: negative regulation of interleukin-17A production

description: Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-17A production.


positive regulation of RNA splicing

description: Any process that activates or increases the frequency, rate or extent of RNA splicing.


name: positive regulation of nitric-oxide synthase biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of a nitric oxide synthase enzyme.


positive regulation of kinase activity

description: Any process that activates or increases the frequency, rate or extent of kinase activity, the catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.


photosystem II stabilization

description: The stabilization of the photosystem II protein complex, resulting from the phosphorylation of its structural protein subunits, in a cell actively involved in photosynthesis.


negative regulation of IP-10 production

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of production of IP-10.


name: positive regulation of tumor necrosis factor production

description: Any process that activates or increases the frequency, rate or extent of tumor necrosis factor production.


regulation of interleukin-22 production

description: Any process that modulates the frequency, rate, or extent of interleukin-22 production.


name: positive regulation of gene expression via chromosomal CpG island demethylation

description: An epigenetic gene regulation mechanism that positively regulates gene expression by demethylation of cytosine residues in chromosomal CpG islands. CpG islands are genomic regions that contain a high frequency of the CG dinucleotide and are often associated with the transcription start site of genes.


name: positive regulation of transforming growth factor beta1 production

description: Any process that activates or increases the frequency, rate, or extent of production of transforming growth factor-beta1.


name: retrotransposon silencing by piRNA-directed DNA methylation

description: A retrotransposon silencing mechanism mediated by Piwi-associated RNA (piRNA)-directed DNA methylation. This results in a heterochromatin assembly, a chromatin conformation that is refractory to transcription.


regulation of lncRNA transcription

description: Any process that modulates the frequency, rate or extent of the synthesis of a lncRNA.


name: positive regulation of interleukin-11 production

description: Any process that activates or increases the frequency, rate, or extent of interleukin-11 production.


name: negative regulation of hydrogen peroxide metabolic process

description: Any process that decreases the frequency, rate or extent of the chemical reactions and pathways involving hydrogen peroxide.


name: regulation of membrane lipid metabolic process

description: Any process that modulates the frequency, rate or extent of membrane lipid metabolic process.


name: positive regulation of removal of superoxide radicals

description: Any process that activates or increases the frequency, rate or extent of removal of superoxide radicals.


negative regulation of xenophagy

description: Any process that stops, prevents or reduces the frequency, rate or extent of xenophagy.


regulation of tRNA methylation

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving tRNA methylation.


name: regulation of diacylglycerol kinase activity

description: Any process that modulates the frequency, rate or extent of diacylglycerol kinase activity.


name: negative regulation of amylopectin catabolic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of amylopectin catabolic process.


negative regulation of phosphorylation

description: Any process that stops, prevents or decreases the rate of addition of phosphate groups to a molecule.


name: positive regulation of interleukin-18 production

description: Any process that activates or increases the frequency, rate, or extent of interleukin-18 production.


name: positive regulation of snRNA transcription by RNA polymerase II

description: Any process that activates or increases the frequency, rate or extent of snRNA transcription mediated by RNA polymerase II.


name: negative regulation of interleukin-15 production

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-15 production.


name: nuclear-transcribed mRNA catabolic process, meiosis-specific transcripts

description: The chemical reactions and pathways resulting in the selective degradation of meiosis-specific transcripts during vegetative growth, by a mechanism that requires determinant of selective removal (DSR) sequences in the targeted mRNAs and involves a YTH family protein.


name: regulation of regulatory ncRNA processing

description: Any process that modulates the frequency, rate or extent of regulatory non-coding RNA processing.


name: RNAi-mediated antiviral immunity against DNA virus

description: An RNAi-mediated post-transcriptional gene silencing pathway induced by DNA viruses leading to a sequence-specific degradation of target mRNAs or inhibition of translation. In plants, DCL3 is the primary Dicer to detect DNA viruses.


name: positive regulation of transcription initiation by RNA polymerase II

description: Any process that increases the rate, frequency or extent of a process involved in starting transcription from an RNA polymerase II promoter.


name: negative regulation of (1->3)-beta-D-glucan biosynthetic process

description: Any process that decreases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of (1->3)-beta-D-glucans.


name: negative regulation of thyroid hormone generation

description: Any process that stops, prevents or reduces the frequency, rate or extent of thyroid hormone generation.


name: positive regulation of mRNA splicing, via spliceosome

description: Any process that activates or increases the rate or extent of mRNA splicing via a spliceosomal mechanism.


name: positive regulation of hormone biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of hormones.


name: positive regulation of cytokine production

description: Any process that activates or increases the frequency, rate or extent of production of a cytokine.


regulation of replicative senescence

description: Any process that modulates the frequency, rate or extent of replicative senescence.


name: negative regulation of chemokine (C-C motif) ligand 1 production

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of production of chemokine (C-C motif) ligand 1.


cytoplasmic sequestering of NF-kappaB

description: The selective interaction of the transcription factor NF-kappaB with specific molecules in the cytoplasm, thereby inhibiting its translocation into the nucleus.


name: negative regulation of phosphate metabolic process

description: Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving phosphates.


name: siRNA-mediated retrotransposon silencing by heterochromatin formation

description: A retrotransposon silencing mechanism in which a siRNA triggers heterochromatin assembly. Heterochromatin is a chromatin conformation that is refractory to transcription.


name: negative regulation of interleukin-21 production

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-21 production.


name: regulation of methane biosynthetic process from methylamine

description: Any process that modulates the frequency, rate or extent of methane biosynthetic process from methylamine.


name: positive regulation of phosphatidic acid biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of phosphatidic acid biosynthetic process.


name: regulation of macrophage cytokine production

description: Any process that modulates the rate, frequency or extent of macrophage cytokine production. Macrophage cytokine production is the appearance of a chemokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.


name: regulation of interleukin-17A production

description: Any process that modulates the frequency, rate or extent of interleukin-17A production.


name: dosage compensation by hyperactivation of X chromosome

description: Compensating for the two-fold variation in X-chromosome:autosome ratios between sexes by a global hyperactivation of all, or most of, the genes on the X-chromosome in the heterogametic sex, leading to a two-fold increase in gene expression from this chromosome. An example of this is found in Drosophila melanogaster.


name: negative regulation of isoprenoid metabolic process

description: Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving isoprenoid.


name: negative regulation of cellular organohalogen metabolic process

description: Any process that decreases the rate, frequency or extent of the chemical reactions and pathways involving organohalogen compounds, as carried out by individual cells.


name: negative regulation of cytokine production involved in inflammatory response

description: Any process that stops, prevents or reduces the frequency, rate or extent of cytokine production involved in inflammatory response.


negative regulation of aggrephagy

description: Any process that stops, prevents or reduces the frequency, rate or extent of aggrephagy.


name: positive regulation of purine nucleotide biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of purine nucleotide biosynthetic processes.


negative regulation of macroautophagy

description: Any process that stops, prevents, or reduces the frequency, rate or extent of macroautophagy.


name: positive regulation of thiamine biosynthetic process

description: Any process that increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of thiamine.


description: The organization of chromatin into heterochromatin at the pericentric region of a chromosome.


regulation of glucokinase activity

description: Any process that modulates the frequency, rate or extent of glucokinase activity, the catalysis of the transfer of a phosphate group, usually from ATP, to a glucose molecule.


name: negative regulation of phospholipid biosynthetic process

description: Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of phospholipids.


regulation of telomerase activity

description: Any process that modulates the frequency, rate or extent of telomerase activity, the catalysis of the reaction: deoxynucleoside triphosphate + DNA(n) = diphosphate + DNA(n+1). Telomerases catalyze extension of the 3'- end of a DNA strand by one deoxynucleotide at a time using an internal RNA template that encodes the telomeric repeat sequence.


name: negative regulation of glial cell-derived neurotrophic factor production

description: Any process that stops, prevents or reduces the frequency, rate or extent of glial cell-derived neurotrophic factor production.


name: regulation of plant-type cell wall cellulose biosynthetic process

description: Any process that modulates the frequency, rate or extent of plant-type cell wall cellulose biosynthetic process.


name: positive regulation of gene expression, epigenetic

description: An epigenetic process that increases gene expression at specific genomic regions through chromatin remodeling either by modifying higher order chromatin fiber structure, nucleosomal histones, or the cytosine DNA demethylation.


name: positive regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization

description: Any process that activates or increases the frequency, rate or extent of parkin-mediated mitophagy in response to mitochondrial depolarization.


name: negative regulation of autophagosome maturation

description: Any process that stops, prevents or reduces the frequency, rate or extent of autophagosome maturation.


name: negative regulation of phosphorus utilization

description: Any process that stops, prevents, or reduces the frequency, rate or extent of phosphorus utilization.


name: positive regulation of cellular senescence

description: Any process that activates or increases the frequency, rate or extent of cellular senescence.


name: regulation of cellular biosynthetic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of substances, carried out by individual cells.


name: positive regulation of phospholipid biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of phospholipids.


name: positive regulation of platelet-derived growth factor production

description: Any process that increases the rate, frequency, or extent of the appearance of any platelet-derived growth factor due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.


photosynthetic state transition

description: A regulation of the phtosynthetic light reaction in which the light harvesting antenna complexes transition between photosystems.


name: negative regulation of alkaline phosphatase activity

description: Any process that decreases the frequency, rate or extent of alkaline phosphatase activity, the catalysis of the reaction: an orthophosphoric monoester + H2O = an alcohol + phosphate, with an alkaline pH optimum.


name: positive regulation of isoprenoid metabolic process

description: Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving isoprenoid.


name: negative regulation of mitochondrial ATP synthesis coupled proton transport

description: Any process that stops, prevents or reduces the frequency, rate or extent of mitochondrial ATP synthesis coupled proton transport.


name: positive regulation of phosphorus metabolic process

description: Any process that increases the frequency, rate or extent of the chemical reactions and pathways involving phosphorus or compounds containing phosphorus.


positive regulation of xenophagy

description: Any process that activates or increases the frequency, rate or extent of xenophagy.


histone mRNA catabolic process

description: The chemical reactions and pathways resulting in the breakdown of histone messenger RNA (mRNA).


name: regulation of inositol trisphosphate biosynthetic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of inositol trisphosphate.


name: positive regulation of interleukin-15 production

description: Any process that activates or increases the frequency, rate, or extent of interleukin-15 production.


name: regulation of phosphatidate phosphatase activity

description: Any process that modulates the frequency, rate or extent of phosphatidate phosphatase activity.


name: nuclear-transcribed mRNA catabolic process, 5'-3' exonucleolytic nonsense-mediated decay

description: The chemical reactions and pathways resulting in the breakdown of the nuclear-transcribed mRNA transcript body of an mRNA in which an amino-acid codon has changed to a nonsense codon; occurs when the 5' end is not protected by a 5'-cap; degradation proceeds in the 5' to 3' direction.


name: regulation of dendritic cell cytokine production

description: Any process that modulates the frequency, rate, or extent of dendritic cell cytokine production.


name: positive regulation of estrogen biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of estrogen biosynthetic process.


facultative heterochromatin formation

description: The compaction of chromatin into a conformation that is refactory to transcription but that be converted to euchromatin and allow transcription in specific contexts. These can be temporal (e.g., developmental states or specific cell-cycle stages), spatial (e.g., nuclear localization changes from the center to the periphery or vice versa due to exogenous factors/signals), or parental/heritable (e.g., monoallelic gene expression).


name: regulation of promoter clearance from RNA polymerase II promoter

description: A process that modulates the frequency, rate or extent of the transition from the initiation to the elongation phases of transcription by RNA polymerase II.


name: negative regulation of methane biosynthetic process from methanethiol

description: Any process that stops, prevents or reduces the frequency, rate or extent of methane biosynthetic process from methanethiol.


name: mRNA localization resulting in post-transcriptional regulation of gene expression

description: Any process that modulates the frequency, rate or extent of gene expression after the production of a mRNA transcript by its transport into, or maintenance in, a specific location within the cell.


name: regulation of steroid hormone biosynthetic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of steroid hormones,compounds with a 1, 2, cyclopentanoperhydrophenanthrene nucleus that act as hormones.


name: positive regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay

description: Any process that activates or increases the frequency, rate or extent of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay.


name: positive regulation of reactive oxygen species biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of reactive oxygen species biosynthetic process.


name: regulation of gene silencing by regulatory ncRNA

description: Any process that regulates the rate, frequency, or extent of gene silencing by RNA. Gene silencing by RNA is the process in which RNA molecules inactivate expression of target genes.


name: negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity

description: Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity.


name: positive regulation of interleukin-34 production

description: Any process that activates or increases the frequency, rate or extent of interleukin-34 production.


name: regulation of termination of RNA polymerase II transcription

description: Any process that modulates the frequency, rate or extent of termination of RNA polymerase II transcription.


regulation of miRNA transcription

description: Any process that modulates the frequency, rate or extent of microRNA (miRNA) gene transcription.


name: positive regulation of interferon-beta production

description: Any process that activates or increases the frequency, rate, or extent of interferon-beta production.


name: positive regulation of pyrimidine-containing compound salvage

description: Any process that activates or increases the frequency, rate or extent of pyrimidine-containing compound salvage.


name: positive regulation of juvenile hormone metabolic process

description: Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving juvenile hormone.


negative regulation of bioluminescence

description: Any process that stops, prevents or reduces the frequency, rate or extent of bioluminescence.


name: regulation of mRNA stability involved in response to stress

description: Any process that modulates the propensity of mRNA molecules to degradation that is part of a change in state or activity of a cell as a result of an exogenous disturbance.


name: negative regulation of phosphatidylcholine catabolic process

description: Any process that decreases the rate, frequency or extent of phosphatidylcholine catabolism. Phosphatidylcholine catabolic processes are the chemical reactions and pathways resulting in the breakdown of phosphatidylcholines, any of a class of glycerophospholipids in which the phosphatidyl group is esterified to the hydroxyl group of choline.


name: deadenylation-dependent decapping of nuclear-transcribed mRNA

description: Cleavage of the 5'-cap of a nuclear mRNA triggered by shortening of the poly(A) tail to below a minimum functional length.


regulation of amphiregulin production

description: Any process that modulates the frequency, rate, or extent of production of amphiregulin.


name: positive regulation of interleukin-25 production

description: Any process that activates or increases the frequency, rate, or extent of interleukin-25 production.


name: regulation of brassinosteroid biosynthetic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of brassinosteroids.


positive regulation of rRNA processing

description: Any process that activates or increases the frequency, rate or extent of rRNA processing.


name: negative regulation of MHC class I biosynthetic process

description: Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of MHC class I.


regulation of interleukin-12 production

description: Any process that modulates the frequency, rate, or extent of interleukin-12 production.


name: positive regulation of hydrogen sulfide biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of hydrogen sulfide biosynthetic process.


name: regulation of coenzyme A biosynthetic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving coenzyme A.


name: regulation of heptadecane biosynthetic process

description: Any process that modulates the frequency, rate or extent of heptadecane biosynthetic process.


name: positive regulation of octadecene metabolic process

description: Any process that activates or increases the frequency, rate or extent of octadecene metabolic process.


name: negative regulation of methane biosynthetic process from dimethyl sulfide

description: Any process that stops, prevents or reduces the frequency, rate or extent of methane biosynthetic process from dimethyl sulfide.


name: positive regulation of interleukin-35 production

description: Any process that activates or increases the frequency, rate, or extent of interleukin-35 production.


name: negative regulation of interleukin-8 production

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-8 production.


name: regulation of vitamin D biosynthetic process

description: Any process that modulates the rate frequency or extent of a vitamin D biosynthetic process. Vitamin D biosynthesis is the chemical reactions and pathways resulting in the formation of vitamin D, any of a group of related, fat-soluble compounds that are derived from delta-5,7 steroids and play a central role in calcium metabolism. Specific forms of vitamin D include calciferol (ergocalciferol; vitamin D2) and cholecalciferol (calciol; vitamin D3).


name: positive regulation of macrophage cytokine production

description: Any process that increases the rate, frequency or extent of macrophage cytokine production. Macrophage cytokine production is the appearance of a chemokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.


name: retrotransposon silencing by siRNA-directed DNA methylation

description: A retrotransposon silencing mechanism mediated by RNA-directed DNA methylation. RNA-directed DNA methylation is a gene silencing process in which small interfering RNAs (siRNAs) guide DNA methylation to the siRNA-generating genomic loci and other loci that are homologous to the siRNAs for de novo DNA methylation. This results in a heterochromatin assembly, a chromatin conformation that is refractory to transcription.


name: regulation of antimicrobial peptide production

description: Any process that modulates the frequency, rate, or extent of antimicrobial peptide production.


name: negative regulation of receptor catabolic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of receptor catabolic process.


name: positive regulation of interleukin-12 production

description: Any process that activates or increases the frequency, rate, or extent of interleukin-12 production.


name: regulation of alpha-glucan biosynthetic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways relusting in the formation of alpha-glucans.


name: positive regulation of inositol-polyphosphate 5-phosphatase activity

description: Any process that increases the rate or frequency of inositol-polyphosphate 5-phosphatase activity, the catalysis of the reactions: D-myo-inositol 1,4,5-trisphosphate + H2O = myo-inositol 1,4-bisphosphate + phosphate, and 1D-myo-inositol 1,3,4,5-tetrakisphosphate + H2O = 1D-myo-inositol 1,3,4-trisphosphate + phosphate.


name: negative regulation of production of molecular mediator of immune response

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of the production of molecular mediator of immune response.


name: negative regulation of oxytocin production

description: Any process that stops, prevents, or reduces the rate of production of oxytocin.


name: positive regulation of interleukin-22 production

description: Any process that activates or increases the frequency, rate, or extent of interleukin-22 production.


name: regulation of glycogen biosynthetic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of glycogen.


name: positive regulation of interleukin-3 production

description: Any process that activates or increases the frequency, rate, or extent of interleukin-3 production.


name: positive regulation of glycolytic fermentation to ethanol

description: Any process that activates or increases the frequency, rate or extent of glucose catabolic process to ethanol.


autosome genomic imprinting

description: The establishment of epigenetic modifications (imprints) in autosomal (non-sexual) chromosomes during gametogenesis, and propagation of these imprints during the organism's life. Genomic imprinting leads to an asymmetry between the maternal and paternal alleles and differential expression of the corresponding alleles. This can happen through heterochromatin formation or differential chromatin loop formation.


name: positive regulation of pyrimidine nucleotide biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of pyrimidine nucleotide biosynthetic process.


name: regulation of 18-methylnonadec-1-ene biosynthetic process

description: Any process that modulates the frequency, rate or extent of 18-methylnonadec-1-ene biosynthetic process.


name: negative regulation of ergosterol biosynthetic process

description: Any process that decreases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of ergosterol.


name: regulation of cellulose biosynthetic process

description: Any process that modulates the frequency, rate or extent of cellulose biosynthetic process.


name: negative regulation of hexadecanal biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of hexadecanal biosynthetic process.


description: The formation of heterochromatin into a heterochromatin domain, enriched in histone H3 methylated on lysine 9 (H3K9me), by a process mediated by a Piwi-associated RNA (piRNA).


name: positive regulation of chemokine (C-X-C motif) ligand 1 production

description: Any process that activates or increases the frequency, rate or extent of chemokine (C-X-C motif) ligand 1 production.


name: positive regulation of amylopectin catabolic process

description: Any process that activates or increases the frequency, rate or extent of amylopectin catabolic process.


name: positive regulation of T-helper 1 cell cytokine production

description: Any process that activates or increases the frequency, rate or extent of T-helper 1 cell cytokine production.


regulation of snoRNA processing

description: Any process that modulates the frequency, rate or extent of snoRNA processing.


photosystem stoichiometry adjustment

description: Adjustment of Photosystem I/Photosystem II ratio in response to light conditions. The function of photosystem stoichiometry adjustment is to compensate for any deficiency in energy conversion at either photosystem I or photosystem II by increasing the quantity the photosystem that will otherwise become the rate-limiting to overall photosynthesis.


name: regulation of interferon-alpha production

description: Any process that modulates the frequency, rate, or extent of interferon-alpha production.


name: negative regulation of macrophage inflammatory protein-1 gamma production

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of production of macrophage inflammatory protein-1 gamma.


name: regulation of pentadecane metabolic process

description: Any process that modulates the frequency, rate or extent of pentadecane metabolic process.


name: positive regulation of post-transcriptional gene silencing

description: Any process that increases the frequency, rate or extent of the inactivation of gene expression by a posttranscriptional mechanism.


name: positive regulation of phytol biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of phytol biosynthetic process.


name: negative regulation of interleukin-7 production

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-7 production.


name: negative regulation of tumor necrosis factor production

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of tumor necrosis factor production.


name: regulation of hydrogen sulfide biosynthetic process

description: Any process that modulates the frequency, rate or extent of hydrogen sulfide biosynthetic process.


name: regulation of mitochondrial electron transport, NADH to ubiquinone

description: Any process that modulates the frequency, rate or extent of mitochondrial electron transport, NADH to ubiquinone.


name: regulation of transforming growth factor beta1 production

description: Any process that modulates the frequency, rate, or extent of production of transforming growth factor-beta1.


name: regulation of mRNA cis splicing, via spliceosome

description: Any process that modulates the frequency, rate or extent of mRNA cis splicing, via spliceosome.


RNAi-mediated antiviral immune response

description: A post-transcriptional gene silencing pathway mediated by the action of regulatory RNAs that protects against foreign organism invasion by restricting viral replication and dissemination.


name: positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria

description: Any process that activates or increases the frequency, rate, or extent of biosynthesis of antibacterial peptides active against Gram-positive bacteria.


name: regulation of myeloid dendritic cell cytokine production

description: Any process that modulates the frequency, rate, or extent of myeloid dendritic cell cytokine production.


name: negative regulation of sphingolipid biosynthetic process

description: Any process that decreases the rate, frequency or extent of sphingolipid biosynthesis. Sphingolipid biosynthesis is the chemical reactions and pathways resulting in the formation of sphingolipids, any of a class of lipids containing the long-chain amine diol sphingosine or a closely related base (a sphingoid).


name: regulation of (1->3)-beta-D-glucan biosynthetic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of (1->3)-beta-D-glucans.


name: positive regulation of DNA amplification

description: Any process that activates or increases the frequency, rate or extent of DNA amplification.


positive regulation of bioluminescence

description: Any process that activates or increases the frequency, rate or extent of bioluminescence.


name: regulation of hexadecanal biosynthetic process

description: Any process that modulates the frequency, rate or extent of hexadecanal biosynthetic process.


name: regulation of electron transfer activity

description: Any process that modulates the frequency, rate or extent of electron transfer activity.


name: negative regulation of cellulose biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of cellulose biosynthetic process.


name: epigenetic programing of female pronucleus

description: The global programming of epigenetic modifications in the female pronucleus of the newly fertilized zygote. The maternal genome is protected from global DNA demethylation before the first division of the zygote, and instead undergoes passive, replication-dependent demethylation during early embryogenesis, arising from inhibition of the DNA maintenance methyltransferase Dnmt1.


name: positive regulation of auxin biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of auxins, plant hormones that regulate aspects of plant growth.


name: positive regulation of chemokine (C-C motif) ligand 6 production

description: Any process that activates or increases the frequency, rate, or extent of production of chemokine (C-C motif) ligand 6 (CCL6).


negative regulation of gluconeogenesis

description: Any process that stops, prevents, or reduces the frequency, rate or extent of gluconeogenesis.


regulation of interleukin-9 production

description: Any process that modulates the frequency, rate, or extent of interleukin-9 production.


regulation of nitrate assimilation

description: Any process that modulates the rate, frequency, or extent of the uptake, from the environment, of nitrates, inorganic or organic salts and esters of nitric acid and the subsequent reduction of nitrate ion to other, less highly oxidized, inorganic nitrogenous substances.


name: positive regulation of reverse transcription

description: Any process that activates or increases the frequency, rate or extent of reverse transcription.


constitutive heterochromatin formation

description: The compaction of chromatin into a conformation that is refactory to transcription.


name: positive regulation of auxin metabolic process

description: Any process that increases the frequency, rate or extent of the chemical reactions and pathways involving auxins, plant hormones that regulate aspects of plant growth.


name: regulation of 3'-UTR-mediated mRNA stabilization

description: Any process that modulates the frequency, rate or extent of 3'-UTR-mediated mRNA stabilization.


name: regulation of estrogen biosynthetic process

description: Any process that modulates the frequency, rate or extent of estrogen biosynthetic process.


name: regulation of juvenile hormone biosynthetic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of juvenile hormone.


negative regulation of mitophagy

description: Any process that stops, prevents or reduces the frequency, rate or extent of mitophagy.


name: negative regulation of cellular senescence

description: Any process that stops, prevents or reduces the frequency, rate or extent of cellular senescence.


name: negative regulation of brassinosteroid biosynthetic process

description: Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of brassinosteroids.


name: negative regulation of type III interferon production

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of type III interferon production. Interferon lambda is the only member of the type III interferon found so far.


name: regulation of chemokine (C-C motif) ligand 20 production

description: Any process that modulates the frequency, rate or extent of chemokine (C-C motif) ligand 20 production.


name: regulation of chemokine (C-C motif) ligand 1 production

description: Any process that modulates the frequency, rate, or extent of production of chemokine (C-C motif) ligand 1.


name: regulation of transcription from RNA polymerase II promoter by a nonfermentable carbon source

description: A transcription regulation process in which the presence of a nonfermentable carbon source leads to the modulation of the frequency, rate, or extent of transcription, from an RNA polymerase II promoter, of specific genes involved in the metabolism of other carbon sources.


name: cytoplasmic sequestering of transcription factor

description: The selective interaction of a transcription factor with specific molecules in the cytoplasm, thereby inhibiting its translocation into the nucleus.


regulation of phosphatase activity

description: Any process that modulates the rate or frequency of phosphatase activity. Phosphatases catalyze the hydrolysis of phosphoric monoesters, releasing phosphate.


name: regulation of capsule polysaccharide biosynthetic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of polysaccharides that make up the capsule, a protective structure surrounding some species of bacteria and fungi.


name: negative regulation of tatiopterin biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of tatiopterin biosynthetic process.


name: negative regulation of macrophage inflammatory protein 1 alpha production

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of production of macrophage inflammatory protein 1 alpha.


name: negative regulation of (R)-mevalonic acid biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of (R)-mevalonic acid biosynthetic process.


name: regulation of thyroid hormone generation

description: Any process that modulates the frequency, rate or extent of thyroid hormone generation.


regulation of rRNA processing

description: Any process that modulates the frequency, rate or extent of rRNA processing.


name: negative regulation of calcidiol 1-monooxygenase activity

description: Any process that decreases the rate, frequency or extent of calcidiol 1-monooxygenase activity. Calcidiol 1-monooxygenase activity is the catalysis of the reaction: calcidiol + NADPH + H+ + O2 = calcitriol + NADP+ + H2O.


name: regulation of quinolinate biosynthetic process

description: Any process that modulates the frequency, rate or extent of quinolinate biosynthetic process.


name: suppression by virus of host type I interferon production

description: Any viral process that results in the inhibition of host cell type I interferon production. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families.


regulation of endothelin production

description: Any process that modulates the frequency, rate or extent of endothelin production.


name: regulation of transcription by RNA polymerase III

description: Any process that modulates the frequency, rate or extent of transcription mediated by RNA ploymerase III.


name: positive regulation of transcription by galactose

description: Any process involving galactose that activates or increases the rate of transcription.


name: positive regulation of isopentenyl diphosphate biosynthetic process, mevalonate pathway

description: Any process that activates or increases the frequency, rate or extent of isopentenyl diphosphate biosynthetic process, mevalonate pathway.


name: membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2 isoform h1 (human)

description: A membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q86UL8-1.


EOLA1_HUMAN Protein EOLA1 (sprot)

A protein that is a translation product of the EOLA1 gene in human.


protein EOLA1 isoform h2 (human)

A protein EOLA1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8TE69-2.


protein EOLA1 isoform h1 (human)

A protein EOLA1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8TE69-1.


name: alpha-1-antitrypsin N-glycosylated 1 (human)

description: An alpha-1-antitrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-107 of the amino acid sequence represented by UniProtKB:P01009-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P01009-1, Asn-107, MOD:00160~GNO:G00912UN.


JGB_ARATH Protein JINGUBANG (sprot)

A protein that is a translation product of the JGB gene in Arabidopsis thaliana.


hereditary painful callosities

category: biolink:Disease biolink:DiseaseOrPhenotypicFeature biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing

description: Hereditary painful callosities is a nummular palmoplantar keratoderma characterized by the development of painful keratotic lesions over pressure points in hands and feet. A few families have been described. Transmission is autosomal dominant. Successful analgesia can be obtained with tretinoin.


name: YTH domain-containing family protein 3 phosphorylated 1 (human)

description: A YTH domain-containing family protein 3 (human) that has been phosphorylated on the residue at the position equivalent to Thr-115 of the amino acid sequence represented by UniProtKB:Q7Z739. UniProtKB:Q7Z739, Thr-115, MOD:00047.


name: cytosolic carboxypeptidase 1 isoform h1 (human)

description: A cytosolic carboxypeptidase 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9UPW5-1.


name: X-linked sideroblastic anemia with ataxia

description: A rare syndromic, inherited form of sideroblastic anemia in which the cause of the disease is a mutation in the ABCB7 gene and is characterized by mild to moderate anemia (with hypochromia and microcytosis) and early-onset, non- or slowly progressive spinocerebellar ataxia.


name: histone H3.2, initiator methionine removed citrullinated 1 (human)

description: A histone H3.2 (human) that has had the initiator methionine removed and that has been citrullinated at the position equivalent to Arg-9 of the amino acid sequence represented by UniProtKB:Q71DI3. UniProtKB:Q71DI3, 2-136, Arg-9, MOD:00219.


name: switch-associated protein 70 isoform 1 (mouse)

description: A switch-associated protein 70 isoform 1 that is encoded in the genome of mouse.


name: SWP70_MOUSE Switch-associated protein 70 (sprot)

description: A switch-associated protein 70 that is encoded in the genome of mouse.


name: WOR2_CANAL White-opaque regulator 2 (sprot)

description: A protein that is a translation product of the WOR2 gene in Candida albicans SC5314.


name: uncharacterized protein, ppa2 translation product (zebrafish)

description: An inorganic pyrophosphatase 2, mitochondrial that is encoded in the genome of zebrafish.


O77477_DROME LD24471p (trembl)

A small ribosomal subunit protein mS27 that is encoded in the genome of fruit fly.


name: RNA pseudouridine synthase 5 isoform 1 (Arabidopsis thaliana)

description: An RNA pseudouridine synthase 5 (Arabidopsis thaliana) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q5M721-1.


name: PUS5_ARATH RNA pseudouridine synthase 5 (sprot)

description: A protein that is a translation product of the At3g52260 gene in Arabidopsis thaliana.


name: RNA pseudouridine synthase 5 isoform 2 (Arabidopsis thaliana)

description: An RNA pseudouridine synthase 5 (Arabidopsis thaliana) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q5M721-2.


name: glycerol-3-phosphate acyltransferase 4 isoform 1

description: A glycerol-3-phosphate acyltransferase 4 that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q86UL3-1 or a 1:1 ortholog thereof.


name: glycerol-3-phosphate acyltransferase 4 isoform 1 (mouse)

description: A glycerol-3-phosphate acyltransferase 4 isoform 1 that is encoded in the genome of mouse.


name: glycerol-3-phosphate acyltransferase 4 isoform 1 (human)

description: A glycerol-3-phosphate acyltransferase 4 isoform 1 that is encoded in the genome of human.


name: GTR5_RAT Solute carrier family 2, facilitated glucose transporter member 5 (sprot)

description: A solute carrier family 2, facilitated glucose transporter member 5 that is encoded in the genome of rat.


homoallylic alcohol

An aliphatic alcohol where the hydroxy carbon is beta to a double bond.


ricinoleic acid

A (9Z)-12-hydroxyoctadec-9-enoic acid in which the 12-hydroxy group has R-configuration..


A HDoHE obtained by hydroxylation at position 2 of all-cis-docosa-4,7,10,13,16,19-hexaenoic acid.


A hex-3-en-1-ol in which the double bond adopts a Z-configuration. Also known as leaf alcohol, it is emitted by green plants upon mechanical damage. Used as a flavourant in tea.


coprogen B

An Fe(III)-complexed hydroxamate siderophore with formula C33H51FeN6O12 that is secreted by several fungi and bacteria.


pyriculol

A benzaldehyde that is salicylaldehyde which is substituted at position 6 by a (3R,4S,5E)-3,4-dihydroxyhepta-1,5-dien-1-yl group. It is a phytotoxic metabolite, isolated from the rice blast fungi Magnaporthe oryzae and Magnaporthe grisea.


A HEPE obtained by hydroxylation at position 20 of all-cis-5,8,11,14,17-icosapentaenoic acid.


ferrirubin

A member of the class of ferrichromes that is an iron(III) chelate of the homodetic cyclic hexapeptide (cyclo{glycyl-L-seryl-L-seryl-N(5)-hydroxy-N(5)-[(2Z)-5-hydroxy-3-methyl-1-pent-2-enoyl]-L-ornithyl-N(5)-hydroxy-N(5)-[(2Z)-5-hydroxy-3-methyl-1-pent-2-enoyl]-L-ornithyl-N(5)-hydroxy-N(5)-[(2Z)-5-hydroxy-3-methyl-1-pent-2-enoyl]-L-ornithine


coprogen

An iron(III) hydroxamate isolated from fungi and bacteria including Penicillium species and Neurospora crassa. It is a growth factor for coprophilous fungi.


A primary alcohol that is hex-3-ene substituted by a hydroxy group at position 1.


desferricoprogen B

A member of the class of 2,5-diketopiperazines that is 2,5-diketopiperazine which is substituted at positions 3 and 6 by 3-(hydroxyamino)propyl groups in which the nitrogens have been acylated by (2E)-5-hydroxy-3-methylpent-2-enoyl groups. The substituent at position 3 has been further modified by having its terminal hydroxy group esterified by condensation with the carboxy group of N(5)-hydroxy-L-ornithine in which the N(5) nitrogen has been acylated by a (2E)-5-hydroxy-3-methylpent-2-enoyl group.


tuberonic acid

An oxo monocarboxylic acid that is (+)-7-isojasmonic acid in which one of the hydrogens of the side-chain methyl group is replaced by a hydroxy group.


An L-ornithine derivative obtained by formal condensation of the carboxy group of anhydromevalonic acid with the hydroxylamine nitrogen of N(5)-hydroxy-L-ornithine.


desferricoprogen

A member of the class of 2,5-diketopiperazines that is 2,5-diketopiperazine which is substituted at positions 3 and 6 by 3-(hydroxyamino)propyl groups in which the nitrogens have been acylated by (2E)-5-hydroxy-3-methylpent-2-enoyl groups. The substituent at position 3 has been further modified by having its terminal hydroxy group esterified by condensation with the carboxy group of N(2)-acetyl-N(5)-hydroxy-L-ornithine in which the N(5) nitrogen has been acylated by a (2E)-5-hydroxy-3-methylpent-2-enoyl group.


methyl tuberonate

A methyl ester derived from tuberonic acid.


A homoallylic alcohol that is 2-methylpent-2-ene in which a hydrogen of the methyl group at position 5 has been replaced by a hydroxy group.


12-hydroxyjasmonic acid

An oxo carboxylic acid that is jasmonic acid in which one of the hydrogens of the methyl group is replaced by a hydroxy group.


A benzaldehyde that is salicylaldehyde which is substituted at position 6 by a (3S,4S,5E)-3,4-dihydroxyhepta-1,5-dien-1-yl group. It is an epimer of pyriculol with stronger phytotoxic activity.


pyriculariol

A member of the class of benzaldehydes that is salicylaldehyde which is substituted at position 6 by a (1E,3E,5R,6S)-5,6-dihydroxyhepta-1,3-dien-1-yl group. An isomer of pyriculol.


dihydropyriculariol

A hydroxybenzyl alcohol that is pyriculariol in which the aldehyde goup has been reduced to the corresponding alcohol.


An L-isoleucine derivative resulting from the formal condensation of the carboxy group of (+)-12-hydroxy-7-isojasmonic acid with the amino group of L-isoleucine.


A hex-3-en-1-ol in which the double bond adopts an E-configuration.


(9Z)-12-hydroxyoctadec-9-enoic acid

A hydroxy fatty acid that is (9Z)-octadec-9-enoic (oleic) acid carrying a hydroxy substituent at position 12.


dihydropyriculol

A member of the class of benzyl alcohols resulting from the formal reduction of the aldehyde group of pyriculol. Produced by the rice blast fungus Magnaporthe oryzae.


isopentenyl alcohol

A primary alcohol having the structure of isopentyl alcohol but with a double bond between C-3 and one of the C-4 atoms.


6-tuliposide A

A 6-O-acyl-D-glucose that is the 6-O-(4-hydroxy-2-methylenebutanoyl) derivative of D-glucopyranose.


triricinolein

A triglyceride formed by acylation of the three hydroxy groups of glycerol with ricinoleic acid, ((9Z,12R)-12-hydroxydec-9-enoic acid). It is the main constituent of castor oil.


anhydromevalonyl-CoA

A hydroxy fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of anhydromevalonic acid.


A hydroxy fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of 6-hydroxyhex-3-enoic acid.


marinolic acid C

An enoate ester resulting from the formal condensation of the carboxy group of (2E)-4-{(2S,3R,4R,5S)-3,4-dihydroxy-5-[(2E,4R,5S)-5-hydroxy-4-methylhex-2-en-1-yl]oxan-2-yl}-3-methylbut-2-enoic acid with the alcoholic hydroxy group of 8-hydroxyoctanoic acid.


diricinolein

A diglyceride in which any two of the R groups (positions not specified) are acyl groups specified as ricinoleoyl ((9Z,12R)-12-hydroxyoctadec-9-enoyl), while the remaining R group is H.


6-hydroxyhex-3-enoic acid

A medium-chain hydroxy fatty acid comprising 3-hexenoic acid carrying a 6-hydroxy substituent.


A glycol that is 1,4-butanediol substituted at position 2 by a methylidene group.


An L-isoleucine derivative resulting from the formal condensation of the carboxy group of (3R)-12-hydroxyjasmonic acid with the amino group of L-isoleucine.


name: cytochrome P450 708A2 isoform 1 (Arabidopsis thaliana)

description: A cytochrome P450 708A2 (Arabidopsis thaliana) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8L7D5-1.


name: Undifferentiated Juvenile Idiopathic Arthritis

description: A category of juvenile idiopathic arthritis that does not fulfill any single category or has criteria for more than one category.


name: OLF6_CHICK Olfactory receptor-like protein COR6 (sprot)

description: A protein that is a translation product of the COR6 gene in chicken.


name: zinc finger protein AEBP2 isoform h1 (human)

description: A zinc finger protein AEBP2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q6ZN18-1.


name: vasopressin-neurophysin 2-copeptin sequence variant Q23R (human)

description: A vasopressin-neurophysin 2-copeptin (human) that has an Arg residue at the position equivalent to Gln-23 of the amino acid sequence represented by UniProtKB:P01185. UniProtKB:P01185, Gln-23, CHEBI:29952.


name: amyloid beta A4 precursor protein-binding family B member 1-interacting protein methylated 1 (human)

description: An amyloid beta A4 precursor protein-binding family B member 1-interacting protein (human) that has been methylated on the residue at the position equivalent to Cys-381 of the amino acid sequence represented by UniProtKB:Q7Z5R6-1. Example: UniProtKB:Q7Z5R6-1, Cys-381, MOD:00660.


name: pleckstrin homology domain-containing family A member 3 deaminated 1 (human)

description: A pleckstrin homology domain-containing family A member 3 (human) that has been deaminated on the residue at the position equivalent to Gln-288 of the amino acid sequence represented by UniProtKB:Q9HB20. UniProtKB:Q9HB20, Gln-288, MOD:00685.


name: pleckstrin homology domain-containing family A member 3

description: A protein that is a translation product of the human PLEKHA3 gene or a 1:1 ortholog thereof.


name: pleckstrin homology domain-containing family A member 3 cysteinylated 1 (human)

description: A pleckstrin homology domain-containing family A member 3 (human) that has been cysteinylated on the residue at the position equivalent to Cys-163 of the amino acid sequence represented by UniProtKB:Q9HB20. UniProtKB:Q9HB20, Cys-163, MOD:00765.


name: PKHA3_HUMAN Pleckstrin homology domain-containing family A member 3 (sprot)

description: A pleckstrin homology domain-containing family A member 3 that is encoded in the genome of human.


name: PKHA3_MOUSE Pleckstrin homology domain-containing family A member 3 (sprot)

description: A pleckstrin homology domain-containing family A member 3 that is encoded in the genome of mouse.


D-ribitol 5-phosphate

The 5-phospho derivative of D-ribitol.


name: transcription factor E2FA isoform 1 (Arabidopsis thaliana)

description: A transcription factor E2FA (Arabidopsis thaliana) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9FNY0-1.


name: ORP1D_ARATH Oxysterol-binding protein-related protein 1D (sprot)

description: A protein that is a translation product of the ORP1D gene in Arabidopsis thaliana.


name: oxysterol-binding protein-related protein 1D isoform 1 (Arabidopsis thaliana)

description: An oxysterol-binding protein-related protein 1D (Arabidopsis thaliana) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9SAF0-1.


name: calcium/calmodulin-dependent protein kinase type II subunit delta, initiator methionine removed form (human)

description: A calcium/calmodulin-dependent protein kinase type II subunit delta (human) that has had the initiator methionine removed. Example: UniProtKB:Q13557-1, 2-499.


name: metabotropic glutamate receptor 2 isoform 1 (mouse)

description: A metabotropic glutamate receptor 2 isoform 1 that is encoded in the genome of mouse.


name: solute carrier family 13 member 1 isoform 1 (rat)

description: A solute carrier family 13 member 1 isoform 1 that is encoded in the genome of rat.


name: spermatid perinuclear RNA-binding protein isoform 1 (human)

description: A spermatid perinuclear RNA-binding protein isoform 1 that is encoded in the genome of human.


name: spermatid perinuclear RNA-binding protein

description: A protein that is a translation product of the human STRBP gene or a 1:1 ortholog thereof.


name: STRBP_MOUSE Spermatid perinuclear RNA-binding protein (sprot)

description: A spermatid perinuclear RNA-binding protein that is encoded in the genome of mouse.


name: spermatid perinuclear RNA-binding protein deaminated 1 (human)

description: A spermatid perinuclear RNA-binding protein (human) that has been deaminated on the residue at the position equivalent to Asn-396 of the amino acid sequence represented by UniProtKB:Q96SI9-1. Example: UniProtKB:Q96SI9-1, Asn-396, MOD:00684.


name: spermatid perinuclear RNA-binding protein isoform m2 (mouse)

description: A spermatid perinuclear RNA-binding protein (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q91WM1-2.


name: spermatid perinuclear RNA-binding protein methylated 1 (human)

description: A spermatid perinuclear RNA-binding protein (human) that has been methylated on the residue at the position equivalent to Cys-218 of the amino acid sequence represented by UniProtKB:Q96SI9-1. Example: UniProtKB:Q96SI9-1, Cys-218, MOD:00660.


name: STRBP_RAT Spermatid perinuclear RNA-binding protein (sprot)

description: A spermatid perinuclear RNA-binding protein that is encoded in the genome of rat.


name: spermatid perinuclear RNA-binding protein isoform 1 (mouse)

description: A spermatid perinuclear RNA-binding protein isoform 1 that is encoded in the genome of mouse.


name: spermatid perinuclear RNA-binding protein isoform 1

description: A spermatid perinuclear RNA-binding protein that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q96SI9-1 or a 1:1 ortholog thereof.


name: spermatid perinuclear RNA-binding protein isoform h2 (human)

description: A spermatid perinuclear RNA-binding protein (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q96SI9-2.


name: STRBP_CHICK Spermatid perinuclear RNA-binding protein (sprot)

description: A spermatid perinuclear RNA-binding protein that is encoded in the genome of chicken.


name: STRBP_HUMAN Spermatid perinuclear RNA-binding protein (sprot)

description: A spermatid perinuclear RNA-binding protein that is encoded in the genome of human.


name: spermatid perinuclear RNA-binding protein deaminated 2 (human)

description: A spermatid perinuclear RNA-binding protein (human) that has been deaminated on the residue at the position equivalent to Gln-397 of the amino acid sequence represented by UniProtKB:Q96SI9-1. Example: UniProtKB:Q96SI9-1, Gln-397, MOD:00685.


name: inter-alpha-trypsin inhibitor heavy chain H2 O-glycosylated 23 (human)

description: An inter-alpha-trypsin inhibitor heavy chain H2 (human) that has been O-glycosylated at the residue equivalent to Thr-675 of the amino acid sequence represented by UniProtKB:P19823-1, in which the glycan composition is represented by GlyTouCan:G57317CE. Example: UniProtKB:P19823-1, Thr-675, MOD:00005~GNO:G57317CE.


name: Y1561_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56130 (sprot)

description: A protein that is a translation product of the At1g56130 gene in Arabidopsis thaliana.


name: probable LRR receptor-like serine/threonine-protein kinase At1g56130 isoform 2 (Arabidopsis thaliana)

description: A probable LRR receptor-like serine/threonine-protein kinase At1g56130 (Arabidopsis thaliana) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:C0LGH2-2.


name: probable LRR receptor-like serine/threonine-protein kinase At1g56130 isoform 1 (Arabidopsis thaliana)

description: A probable LRR receptor-like serine/threonine-protein kinase At1g56130 (Arabidopsis thaliana) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:C0LGH2-1.


name: ribosome biogenesis protein NOP53 isoform 1 (Arabidopsis thaliana)

description: A ribosome biogenesis protein NOP53 (Arabidopsis thaliana) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O22892-1.


name: von Willebrand factor C domain-containing protein 2-like isoform m2 (mouse)

description: A von Willebrand factor C domain-containing protein 2-like (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q505H4-2.


A beta-hydroxy ketone that is (5R)-5-hydroxyheptan-3-one substituted by a phenyl group at position 1 and a 4-hydroxy-3-methoxyphenyl moiety at position 7. Isolated from Alpinia officinarum, it exhibits antiviral activity against influenza virus.


name: MED9_ARATH Mediator of RNA polymerase II transcription subunit 9 (sprot)

description: A protein that is a translation product of the MED9 gene in Arabidopsis thaliana.


name: elongation factor 1-gamma, initiator methionine removed form (human)

description: An elongation factor 1-gamma (human) that has had the initiator methionine removed. UniProtKB:P26641, 2-437.


WNT1_MOUSE Proto-oncogene Wnt-1 (sprot)

A proto-oncogene Wnt-1 that is encoded in the genome of mouse.


proto-oncogene Wnt-1 isoform 1 (mouse)

A proto-oncogene Wnt-1 isoform 1 that is encoded in the genome of mouse.


name: SCR_DROME Homeotic protein Sex combs reduced (sprot)

description: A protein that is a translation product of the Scr gene in fruit fly.


magnetite nanoparticle

A nanoparticle consisting of magnetite, Fe(2+)Fe(3+)2O4.


name: Stage IVB Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8

description: Stage IVB includes: T0, N3, M0. T0: No evidence of primary tumor. N3: Metastasis in a cervical lymph node larger than 6 cm in greatest dimension and ENE(-); or metastases in a single ipsilateral cervical lymph node larger than 3 cm in greatest dimension and ENE(+); or metastases in multiple ipsilateral, contralateral, or bilateral cervical lymph nodes, any size and ENE(+) in any node. M0: No distant metastasis. (AJCC 8th Ed.)


name: Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy by AJCC v8 Stage

description: A term that refers to the staging of unknown primary tumor (except for EBV-related and HPV-related tumors) and metastatic cervical adenopathy according to the American Joint Committee on Cancer, 8th edition.


name: Stage IVA Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8

description: Stage IVA includes: T0, N2, M0. T0: No evidence of primary tumor. N2: Metastasis in a single ipsilateral or contralateral cervical lymph node 3 cm or smaller in greatest dimension and ENE(+); or metastasis in a single ipsilateral cervical lymph node larger than 3 cm but not larger than 6 cm in greatest dimension and ENE(-); or metastases in multiple ipsilateral cervical lymph nodes, none larger than 6 cm in greatest dimension and ENE(-); or metastases in bilateral or contralateral cervical lymph nodes, none larger than 6 cm in greatest dimension and ENE(-). M0: No distant metastasis. (AJCC 8th Ed.)


name: Stage IVC Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8

description: Stage IVC includes: T0, Any N, M1. T0: No evidence of primary tumor. M1: Distant metastasis. (AJCC 8th Ed.)


name: Stage III Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8

description: Stage III includes: T0, N1, M0. T0: No evidence of primary tumor. N1: Metastasis in a single ipsilateral lymph node, 3 cm or smaller in greatest dimension and ENE (extranodal extension)(-). M0: No distant metastasis. (AJCC 8th Ed.)


name: Recurrent Metastatic Merkel Cell Carcinoma

description: The reemergence of a metastatic Merkel cell carcinoma after a period of remission.


Recurrent Metastatic Malignant Neoplasm

description: The reemergence of a metastatic malignant neoplasm after a period of remission.


Recurrent Metastatic Melanoma

description: The reemergence of metastatic melanoma after a period of remission.


Recurrent Carcinoma of Unknown Primary

description: The reemergence of carcinoma from an unknown primary after a period of remission.


name: Recurrent Metastatic Digestive System Carcinoma

description: The reemergence of a metastatic digestive system carcinoma after a period of remission.


Recurrent Pseudomyxoma Peritonei

description: The reemergence of pseudomyxoma peritonei after a period of remission.


name: Recurrent Metastatic Malignant Neoplasm in the Leptomeninges

description: The reemergence of a metastatic malignant neoplasm in the leptomeninges after a period of remission.


Recurrent Metastatic Gastric Carcinoma

description: The reemergence of metastatic gastric carcinoma after a period of remission.


name: Recurrent Metastatic Skin Squamous Cell Carcinoma

description: The reemergence of a metastatic skin squamous cell carcinoma after a period of remission.


name: dolichol phosphate-mannose biosynthesis regulatory protein sequence variant Y23C, initiator methionine removed form (human)

description: A dolichol phosphate-mannose biosynthesis regulatory protein (human) that has a Cys residue at the position equivalent to Tyr-23 of the amino acid sequence represented by UniProtKB:O94777 and that has had the initiator methionine removed. UniProtKB:O94777, 2-84, Tyr-23, CHEBI:29950.


name: dolichol phosphate-mannose biosynthesis regulatory protein isoform 1 (human)

description: A dolichol phosphate-mannose biosynthesis regulatory protein isoform 1 that is encoded in the genome of human.


name: dolichol phosphate-mannose biosynthesis regulatory protein, initiator methionine removed form (human)

description: A dolichol phosphate-mannose biosynthesis regulatory protein, initiator methionine removed form in human. UniProtKB:O94777, 2-84.


NADPH oxidase 4 isoform m2 (mouse)

An NADPH oxidase 4 (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9JHI8-2.


CD40 ligand N-glycosylated 19 (human)

A CD40 ligand (human) that has been N-glycosylated at the residue equivalent to Asn-240 of the amino acid sequence represented by UniProtKB:P29965-1, in which the glycan structure is represented by GlyTouCan:G78059CC. Example: UniProtKB:P29965-1, Asn-240, MOD:00160~GNO:G78059CC.


name: putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13 cysteinylated 3 (human)

description: A putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13 (human) that has been cysteinylated on the residue at the position equivalent to Cys-265 of the amino acid sequence represented by UniProtKB:Q9NP73-1. Example: UniProtKB:Q9NP73-1, Cys-265, MOD:00765.


DIHYDROGEODIN

A member of the class of benzophenones that is sulochrin in which the hydrogens at positions 3 and 5 are substituted by chloro groups. It is isolated from several Aspergillus species.


F-box/WD repeat-containing protein 4

A protein that is a translation product of the human FBXW4 gene or a 1:1 ortholog thereof.


name: FBXW4_MOUSE F-box/WD repeat-containing protein 4 (sprot)

description: An F-box/WD repeat-containing protein 4 that is encoded in the genome of mouse.


name: FBXW4_HUMAN F-box/WD repeat-containing protein 4 (sprot)

description: An F-box/WD repeat-containing protein 4 that is encoded in the genome of human.


interleukin-3 production

description: The appearance of interleukin-3 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.


micronucleus organization

description: A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the micronucleus.


L-alpha-(methylidenecyclopropyl)glycine

A non-proteinogenic L-alpha-amino acid that is glycine in which one of the methyl hydrogens has been replaced by a 2-methylenecyclopropyl group.


name: gap junction gamma-2 protein isoform 1 (rat)

description: A gap junction gamma-2 protein isoform 1 that is encoded in the genome of rat.


gap junction gamma-2 protein isoform 1

A gap junction gamma-2 protein that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8BQU6-1 or a 1:1 ortholog thereof.


name: gap junction gamma-2 protein isoform 1 (mouse)

description: A gap junction gamma-2 protein isoform 1 that is encoded in the genome of mouse.


protein EVI2A isoform h2 (human)

A protein EVI2A (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P22794-2.


name: symbiont-mediated perturbation of host B-cell mediated immune response

description: A process in which a symbiont alters or subverts the B-cell mediated immune response of the host organism. The host is defined as the larger of the organisms involved in a symbiotic interaction.


name: nuclear receptor ROR-gamma isoform 1 (human)

description: A nuclear receptor ROR-gamma (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P51449-1.


name: nuclear receptor ROR-gamma phosphorylated 1 (human)

description: A nuclear receptor ROR-gamma (human) that has been phosphorylated on the residue at the position equivalent to Ser-113 of the amino acid sequence represented by UniProtKB:P51449-1. Example: UniProtKB:P51449-1, Ser-113, MOD:00046.


name: nuclear receptor ROR-gamma isoform h2 (human)

description: A nuclear receptor ROR-gamma (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P51449-2.


kazrin isoform h2 (human)

A kazrin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q674X7-2.


An optically active 1,2-diacylglycerol 3-diphosphate compound having a 1-hexadecanoyl substituent at the O-1 position and a (Z)-octadec-9-enoyl substituent at the O-2 position.


name: Deafness due to Connexin 26 Gene Anomaly

description: Congenital deafness caused by mutations in the gene GJB2 (deafness gene).


Complete neonatal hearing loss

description: Complete loss of the ability to detect or understand sounds present in an infant within its first month after birth.


Neonatal hearing loss

description: Partial or complete loss of the ability to detect or understand sounds present in an infant within its first month after birth.


name: autosomal recessive nonsyndromic hearing loss 1A

description: An autosomal recessive disorder caused by mutations in the GJB2 gene, encoding gap junction beta-2 protein. The condition is characterized by profound sensorineural hearing loss and may be associated with vestibular dysfunction.


central hearing loss

description: Hearing loss resulting from disorders of the central nervous system auditory pathways.


name: autosomal recessive nonsyndromic hearing loss 49

description: An autosomal recessive disorder caused by mutations in the MARVELD2 gene, encoding MARVEL domain-containing protein 2. The condition is characterized by profound prelingual deafness.


name: autosomal dominant nonsyndromic hearing loss 36

description: Any autosomal dominant nonsyndromic deafness in which the cause of the disease is a mutation in the TMC1 gene.


Hearing Loss, Functional

description: Hearing loss in the absence of auditory system pathology.


name: Mitochondrially Inherited Nonsyndromic Sensorineural Deafness

description: A maternally inherited form of nonsyndromic sensorineural deafness that is caused by a mutation in any of several mitochondrial genes.


Deafness, Autosomal Recessive 12

description: A genetic condition inherited in an autosomal recessive caused by mutation(s) in the CDH23 gene, encoding cadherin-23, characterized by progressive sensorineural hearing loss. Mutation(s) in the CDH23 gene may also cause Usher syndrome 1D.


name: autosomal recessive nonsyndromic hearing loss 36

description: Any autosomal recessive nonsyndromic deafness in which the cause of the disease is a mutation in the ESPN gene.


name: autosomal recessive nonsyndromic hearing loss 28

description: An autosomal recessive disorder caused by mutations in the TRIOBP gene, encoding TRIO and F-actin-binding protein. The condition is characterized by severe to profound sensorineural hearing loss.


Partial neonatal hearing loss

description: Partial loss of the ability to detect or understand sounds present in an infant within its first month after birth.


name: autosomal recessive nonsyndromic hearing loss 39

description: An autosomal recessive disorder caused by mutations in the HGF gene, encoding hepatocyte growth factor receptor. It is characterized by profound deafness.


noise induced hearing loss

description: A condition in which a person loses the ability to hear due to exposure to high intensity sound.


name: autosomal dominant nonsyndromic hearing loss 41

description: Any autosomal dominant nonsyndromic deafness in which the cause of the disease is a mutation in the P2RX2 gene.


hearing loss, X-linked 4

description: Any X-linked nonsyndromic deafness in which the cause of the disease is a mutation in the SMPX gene.


Bilateral Deafness

description: Partial or total inability to hear sounds in both ears.


Deafness, Autosomal Dominant 58

description: A genetic condition inherited in an autosomal dominant fashion linked to chromosome 2p21-p12, characterized by bilateral hearing loss.


name: X-linked hereditary sensory and autonomic neuropathy with hearing loss

description: This syndrome is characterized by the association of an axonal sensory and autonomic neuropathy with hearing loss.


Sensory hearing loss

description: Hearing loss caused by damage to the cochlea in the inner ear.


name: severe intellectual disability-progressive spastic diplegia syndrome

description: Severe intellectual disability-progressive spastic diplegia syndrome is a rare condition that has been described in a few people with severe intellectual disability. Other signs and symptoms include progressive microcephaly (very small head); ataxia (lack of coordination); spasticity ; and/or skin, hair and mild facial anomalies. It is caused by changes (mutations) in the CTNNB1 gene and it is inherited in an autosomal dominant fashion. Treatment is based on the signs and symptoms present in each person.


name: polyadenylate-binding protein RBP47C isoform 2 (Arabidopsis thaliana)

description: A polyadenylate-binding protein RBP47C (Arabidopsis thaliana) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9SX79-2.


name: RB47C_ARATH Polyadenylate-binding protein RBP47C (sprot)

description: A protein that is a translation product of the RBP47C gene in Arabidopsis thaliana.


name: polyadenylate-binding protein RBP47C isoform 1 (Arabidopsis thaliana)

description: A polyadenylate-binding protein RBP47C (Arabidopsis thaliana) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9SX79-1.


LEPR_MOUSE Leptin receptor (sprot)

A leptin receptor that is encoded in the genome of mouse.


leptin receptor isoform E (mouse)

A leptin receptor isoform E that is encoded in the genome of mouse.


leptin receptor isoform D (mouse)

A leptin receptor (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P48356-4.